Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $5.78 million. The enterprise value is -$5.24 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 2.00 million shares outstanding. The number of shares has increased by 139.64% in one year.
| Shares Outstanding | 2.00M |
| Shares Change (YoY) | +139.64% |
| Shares Change (QoQ) | +55.07% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 0.79% |
| Float | 2.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | 0.20 |
| PB Ratio | 0.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.86 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.24 |
Financial Efficiency
Return on equity (ROE) is -15.79% and return on invested capital (ROIC) is -11.94%.
| Return on Equity (ROE) | -15.79% |
| Return on Assets (ROA) | -9.91% |
| Return on Capital (ROIC) | -11.94% |
| Revenue Per Employee | $692,772 |
| Profits Per Employee | -$83,627 |
| Employee Count | 44 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 3.33 |
Taxes
| Income Tax | -60,119 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.50% in the last 52 weeks. The beta is -1.04, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | -1.04 |
| 52-Week Price Change | -99.50% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 73.46 |
| Relative Strength Index (RSI) | 43.63 |
| Average Volume (20 Days) | 84,004 |
Short Selling Information
The latest short interest is 321,526, so 16.08% of the outstanding shares have been sold short.
| Short Interest | 321,526 |
| Short Previous Month | 370,922 |
| Short % of Shares Out | 16.08% |
| Short % of Float | 16.10% |
| Short Ratio (days to cover) | 1.12 |
Income Statement
In the last 12 months, SBFM had revenue of $30.48 million and -$3.68 million in losses. Loss per share was -$142.43.
| Revenue | 30.48M |
| Gross Profit | 9.27M |
| Operating Income | -4.57M |
| Pretax Income | -3.72M |
| Net Income | -3.68M |
| EBITDA | -4.40M |
| EBIT | -4.57M |
| Loss Per Share | -$142.43 |
Full Income StatementBalance Sheet
The company has $11.51 million in cash and $577,358 in debt, giving a net cash position of $10.93 million or $5.47 per share.
| Cash & Cash Equivalents | 11.51M |
| Total Debt | 577,358 |
| Net Cash | 10.93M |
| Net Cash Per Share | $5.47 |
| Equity (Book Value) | 23.49M |
| Book Value Per Share | 20.06 |
| Working Capital | 20.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.91 million and capital expenditures -$664,721, giving a free cash flow of -$11.57 million.
| Operating Cash Flow | -10.91M |
| Capital Expenditures | -664,721 |
| Free Cash Flow | -11.57M |
| FCF Per Share | -$5.79 |
Full Cash Flow StatementMargins
Gross margin is 30.41%, with operating and profit margins of -15.00% and -12.07%.
| Gross Margin | 30.41% |
| Operating Margin | -15.00% |
| Pretax Margin | -12.27% |
| Profit Margin | -12.07% |
| EBITDA Margin | -14.44% |
| EBIT Margin | -15.00% |
| FCF Margin | -37.87% |